§ 882.5820. Implanted cerebellar stimulator.
187 words·~1 min read·
/us/cfr/t21/s§ 882.5820·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. An implanted cerebellar stimulator is a device used to stimulate electrically a patient's cerebellar cortex for the treatment of intractable epilepsy, spasticity, and some movement disorders. The stimulator consists of an implanted receiver with electrodes that are placed on the patient's cerebellum and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.
(b)Classification. Class III (premarket approval).
(c)Date premarket approval application
(PMA)or notice of completion of a product development protocol
(PDP)is required. A PMA or notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before September 26, 1984. Any implanted cerebellar stimulator that was not in commercial distribution before May 28, 1976, or that has not on or before September 26, 1984 been found by FDA to be substantially equivalent to an implanted cerebellar stimulator that was in commercial distribution before May 28, 1976 shall have an approved PMA or declared completed PDP in effect before beginning commercial distribution. [44 FR 51730, Sept. 4, 1979, as amended at 49 FR 26574, June 28, 1984]